[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"notifications-list":3,"$f1teld8c20jaxh":5},{"data":4},[],{"data":6,"error":11},{"id":7,"documentId":8,"slug":9,"name":10,"medical_code":11,"short_description":12,"alternate_name":11,"disambiguating_description":11,"citations":13,"drugs":19,"specialties":34,"cover":11},976,"gcy2dfr7bv8mt5dc5u5pauiy","antineoplastic-agents","Antineoplastic agents",null,"Antineoplastic agents.",[14],{"source":15,"licence":16,"source_url":17,"retrieved_at":18},"European Medicines Agency, Medicines output - medicines report, veterinary rows","EMA and VMD register content, Crown\u002FEU public register","https:\u002F\u002Fwww.ema.europa.eu\u002Fen\u002Fdocuments\u002Freport\u002Fmedicines-output-medicines-report_en.xlsx","2026-09-20",[20,24,28],{"id":21,"documentId":22,"slug":23,"name":23,"active_ingredient":11,"dosage_form":11,"administration_route":11},1873,"e6x2qkjrvbc54u4fc34ugpm7","pegbovigrastim",{"id":25,"documentId":26,"slug":27,"name":27,"active_ingredient":11,"dosage_form":11,"administration_route":11},1880,"zeyamwa4oyp0zw46hsuy362v","toceranib",{"id":29,"documentId":30,"slug":31,"name":31,"active_ingredient":11,"dosage_form":32,"administration_route":33},1898,"buvn3cdy0nmlbjssh1vyaa4t","masitinib","Film-coated tablet","Oral use",[]]